{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "2488108", "DateCompleted": {"Year": "1991", "Month": "04", "Day": "23"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "12"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0920-3206", "JournalIssue": {"Volume": "3", "Issue": "5", "PubDate": {"Year": "1989", "Month": "Oct"}}, "Title": "Cardiovascular drugs and therapy", "ISOAbbreviation": "Cardiovasc Drugs Ther"}, "ArticleTitle": "Antiarrhythmic effect of a new class 1 antiarrhythmic drug, AN-132, on ventricular arrhythmias in beagles.", "Pagination": {"StartPage": "683", "EndPage": "689", "MedlinePgn": "683-9"}, "Abstract": {"AbstractText": ["Using two-stage coronary-ligation-, digitalis- and adrenaline-induced ventricular arrhythmias in beagles, antiarrhythmic effects of AN-132 were examined, and the minimum effective plasma concentration for each arrhythmia model was determined. AN-132 suppressed all the arrhythmias, and the minimum effective plasma concentrations for arrhythmias induced by 24-hour coronary ligation, 48-hour coronary ligation, digitalis, and adrenaline were 3.4-4.6, 1.5-2.3, 0.83, and 9.3 micrograms/ml, respectively. The concentration for adrenaline-induced arrhythmia was significantly higher than that of 24-hour coronary ligation arrhythmia, and it was also higher than that of digitalis arrhythmia. This pharmacologic profile is similar to those of pirmenol and mexiletine. Since AN-132 had no deleterious effects on the hemodynamics and the central nervous system, it may become a clinically useful antiarrhythmic drug."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Yamanashi Medical College, Tamaho-cho, Japan."}], "LastName": "Hashimoto", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Watanabe", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mitsuhashi", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Cardiovasc Drugs Ther", "NlmUniqueID": "8712220", "ISSNLinking": "0920-3206"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "3-(diisopropylaminoethylamino)-2',6'-dimethylpropionanilide, diphosphoric acid"}, {"RegistryNumber": "0", "NameOfSubstance": "Anilides"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Arrhythmia Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Ethylenediamines"}, {"RegistryNumber": "YKH834O4BH", "NameOfSubstance": "Epinephrine"}], "MeshHeadingList": [{"QualifierName": ["blood", "pharmacology"], "DescriptorName": "Anilides"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Arrhythmia Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Arrhythmias, Cardiac"}, {"QualifierName": ["physiology", "surgery"], "DescriptorName": "Coronary Vessels"}, {"QualifierName": [], "DescriptorName": "Digitalis"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["toxicity"], "DescriptorName": "Epinephrine"}, {"QualifierName": ["blood", "pharmacology"], "DescriptorName": "Ethylenediamines"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Ligation"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Tachycardia"}, {"QualifierName": ["drug effects"], "DescriptorName": "Ventricular Function"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Tohoku J Exp Med. 1987 Apr;151(4):443-51", "ArticleIdList": ["3617055"]}, {"Citation": "J Pharmacol Exp Ther. 1982 Dec;223(3):801-10", "ArticleIdList": ["7143241"]}, {"Citation": "Heart Vessels. 1985 Feb;1(1):29-35", "ArticleIdList": ["2419304"]}, {"Citation": "J Pharmacobiodyn. 1981 Nov;4(11):879-85", "ArticleIdList": ["7328489"]}, {"Citation": "Jpn J Pharmacol. 1988 Oct;48(2):273-82", "ArticleIdList": ["3210450"]}, {"Citation": "J Cardiovasc Pharmacol. 1983 Jul-Aug;5(4):538-45", "ArticleIdList": ["6193348"]}, {"Citation": "J Cardiovasc Pharmacol. 1987 Feb;9(2):148-53", "ArticleIdList": ["2435991"]}, {"Citation": "J Cardiovasc Pharmacol. 1984 Mar-Apr;6(2):213-9", "ArticleIdList": ["6200706"]}], "ReferenceList": []}], "History": [{"Year": "1989", "Month": "10", "Day": "1"}, {"Year": "1989", "Month": "10", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1989", "Month": "10", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["2488108", "10.1007/BF01857620"]}}]}